IP
Licensing

We bring our mission to life by working with customers, partners, regulators and governments using innovative approaches to bring biological and biotech products to those who need them most – especially in the developing world.

We advise you on efficient and streamlined technology transfers and successful development, manufacturing and implementation of the project. We also support you through to clinical trials to ensure successful commercialisation.

For each stage from lab scale to Pilot to Commercial scale, our team ensures process optimisation for higher yields while also focusing on batch-to-batch consistency based output, whether the tech transfer is within the organisation or outsourced/out-licensed at any stage. For out-licencing, we also support you by conducting a thorough due diligence that allows you to seal the deal with zero stress.

Our deliverables include

• End-to-end tech transfers for polysaccharide, recombinant and toxoid
  based vaccine development and commercial manufacturing
• End-to-end tech transfer support for biosimilar development and
  manufacturing
• Supplies of finished products, unformulated, formulated (ready-to-fill bulks)
  for various vaccine antigens and biosimilar products
• Our clients include pharma and biotech companies as well as lifesciences
  and financial investors.